Artigo
Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella
Registro en:
Bmc Microbiology. London: Biomed Central Ltd, v. 13, 9 p., 2013.
1471-2180
10.1186/1471-2180-13-217
WOS:000325693400001
WOS000325693400001.pdf
Autor
Chibebe Junior, Jose [UNESP]
Sabino, Caetano P.
Tan, Xiaojiang
Junqueira, Juliana C. [UNESP]
Wang, Yan
Fuchs, Beth B.
Jorge, Antonio O. C. [UNESP]
Tegos, George P.
Hamblin, Michael R.
Mylonakis, Eleftherios
Resumen
Background: Candida spp. are recognized as a primary agent of severe fungal infection in immunocompromised patients, and are the fourth most common cause of bloodstream infections. Our study explores treatment with photodynamic therapy (PDT) as an innovative antimicrobial technology that employs a nontoxic dye, termed a photosensitizer (PS), followed by irradiation with harmless visible light. After photoactivation, the PS produces either singlet oxygen or other reactive oxygen species (ROS) that primarily react with the pathogen cell wall, promoting permeabilization of the membrane and cell death. The emergence of antifungal-resistant Candida strains has motivated the study of antimicrobial PDT (aPDT) as an alternative treatment of these infections. We employed the invertebrate wax moth Galleria mellonella as an in vivo model to study the effects of aPDT against C. albicans infection. The effects of aPDT combined with conventional antifungal drugs were also evaluated in G. mellonella.Results: We verified that methylene blue-mediated aPDT prolonged the survival of C. albicans infected G. mellonella larvae. The fungal burden of G. mellonella hemolymph was reduced after aPDT in infected larvae. A fluconazole-resistant C. albicans strain was used to test the combination of aPDT and fluconazole. Administration of fluconazole either before or after exposing the larvae to aPDT significantly prolonged the survival of the larvae compared to either treatment alone.Conclusions: G. mellonella is a useful in vivo model to evaluate aPDT as a treatment regimen for Candida infections. The data suggests that combined aPDT and antifungal therapy could be an alternative approach to antifungal-resistant Candida strains. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Science and Technology Planning Project of Guangdong Province, P.R. China Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) NIH US Air Force MFEL Program Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, BR-12245000 Sao Jose Dos Campos, SP, Brazil Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA Fac Pindamonhangaba, Dept Restorat Dent, BR-12422970 Pindamonhangaba, SP, Brazil Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA Nucl & Energy Res Inst, Ctr Lasers & Applicat, BR-05508000 Sao Paulo, Brazil Southern Med Univ, Huiqiao Dept, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02114 USA MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Providence, RI 02903 USA Brown Univ, Warren Alpert Med Sch, Miriam Hosp, Providence, RI 02903 USA Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, BR-12245000 Sao Jose Dos Campos, SP, Brazil CAPES: PDEE 2507-11-0 Science and Technology Planning Project of Guangdong Province, P.R. China2011B080701091 FAPESP: 12/19915-6 NIHRO1 AI050875 NIH5U54MH084690-02 US Air Force MFEL ProgramFA9550-04-1-0079